🔎 Trials Near Me

Acasă › Supraponderalitate › Alabama

Studii clinice pentru Supraponderalitate în Alabama

31 studii pentru Supraponderalitate caută participanți în Alabama.

Orașe în Alabama

Text oficial al studiului (în engleză)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Cahaba Research - Pelham /ID# 282381, Pelham
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 1 oct. 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • Univ of Alabama Birmingham, Birmingham
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 30 sept. 2026 · NCT07533175

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

  • Cullman Clinical Trials, Cullman
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT07823608

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

  • AMR Clinical - Mobile, Mobile
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 29 sept. 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Pinnacle Research Group LLC, Anniston
  • Univ of Alabama Birmingham, Birmingham
  • Chambliss Clinical Trials LLC, Montgomery
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07720271

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • University of Alabama - Birmingham, Birmingham
În curs de recrutareFaza 2
Vârste de la 18 la 75 · Toate sexele · Actualizat 28 sept. 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Pinnacle Research Group, LLC, Anniston
  • Central Research Associates, Birmingham
  • Cahaba Research - Pelham, Pelham
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Digestive Health Specialists, Dothan
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Digestive Health Specialists, Dothan
În curs de recrutareFaza 3
Vârste de la 18 la 70 · Toate sexele · Actualizat 24 sept. 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • MFA Clinical Research, Tuscaloosa
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Alliance For Multispecialty Research - Daphne, Daphne
  • Eastern Shore Research Institute, Fairhope
  • Heart Center Research LLC, Huntsville
  • și încă 2
În curs de recrutareFaza 3
Vârste de la 45 la 99 · Toate sexele · Actualizat 22 sept. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Birmingham Clinical Research, Birmingham
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Cullman Clinical Trials, Cullman
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07369011

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • AMR Clinical, Mobile
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Birmingham Clinical Research, Birmingham
  • Cullman Clinical Trials, Cullman
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Fairhope
  • Research Site, Huntsville
  • Research Site, Mobile
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Birmingham
  • AURORA-1 Clinical Site, Huntsville
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Birmingham
  • AURORA-2 Clinical Site, Huntsville
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 16 sept. 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Lakeview Clinical Research, Guntersville
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Pinnacle Research Group, Anniston
  • Alabama Clinical Therapeutics, Birmingham
  • University of Alabama at Birmingham, Birmingham
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 14 sept. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Birmingham
În curs de recrutareFaza 3Voluntari sănătoși bineveniți
Vârste de la 18 la 79 · Toate sexele · Actualizat 11 sept. 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • Uni of Alabama at Birmingham, Birmingham
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 9 sept. 2026 · NCT07770841

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Anniston
  • Kailera Clinical Site, Birmingham
  • Kailera Clinical Site, Cullman
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Pinnacle Research Group LLC, Anniston
  • Alliance For Multispecialty Research - Daphne, Daphne
  • Alliance for Multispecialty Research Mobile, Mobile
În curs de recrutareFaza 3
Vârste de la 18 la 99 · Toate sexele · Actualizat 3 sept. 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Cullman
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT07284901

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Cahaba Research, Inc., Pelham
În curs de recrutareFaza 3
Vârste de la 18 la 99 · Toate sexele · Actualizat 27 aug. 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Dothan
  • Research Site, Huntsville
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 25 aug. 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Birmingham
  • ACCOMPLISH-1 Research Site, Birmingham
În curs de recrutareFaza 3
Vârste de la 18 la 79 · Toate sexele · Actualizat 10 aug. 2026 · NCT07654361

Time-restricted Eating for Postpartum Weight Loss

  • University of Alabama at Birmingham, Birmingham
În curs de recrutare
Vârste de 18 ani și peste · Femei · Actualizat 29 iun. 2026 · NCT06491537

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

  • University of Alabama at Birmingham, Birmingham
În curs de recrutare
Vârste de la 18 la 45 · Femei · Actualizat 24 iun. 2026 · NCT05124808

FELLAShip to Better Health

  • The Worship Center Cristian Church, Birmingham
În curs de recrutare
Vârste de 18 ani și peste · Bărbați · Actualizat 22 ian. 2026 · NCT07220213

Sursă: ClinicalTrials.gov, date preluate la 2 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.